Background on Creative PEGWorks website - leading PEG supplier.

mPEG-SAS, MW 30k

mPEG-SAS, MW 30k

Catalog No: PSB-2116
Product Name: mPEG-SAS, MW 30k
In Stock: Yes
SKUProduct Name
PSB-2116-10g
mPEG-SAS, MW 30k - 10g
$1,450.00
-
+
PSB-2116-5g
mPEG-SAS, MW 30k - 5g
$950.00
-
+
PSB-2116-1g
mPEG-SAS, MW 30k - 1g
$350.00
-
+
Interested in Bulk Orders? Please contact us here

Description

mPEG-SAS is one type of mPEG-NHS ester reagents. There is a C3 aliphatic amide linkage between PEG and the NHS ester. mPEG-SAS name: O-[(N-Succinimidyl)succinyl-aminoethyl]-O-methylpolyethylene glycol, CAS Number 92451-00-8. SAS stands for SAS: SuccinAmide Succinimidyl ester. There is an internal amide linkage between PEG and the succinimidyl NHS ester.

Properties

Q: What are the differences among your PEG NHS ester products?

A: We offer a variety of PEG acid and PEG NHS ester. These NHS esters react with primary and secondary amine to form a stable amide linkage. This reaction may be carried out in an organic solution with an organic base or may be carried out in an aqueous solution at or around neutral pH or slightly acidic or basic.

To PEGylate proteins or nanoparticles, it often requires a large excess of PEG NHS esters due to the competitive hydrolysis reaction in an aqueous solution. Stability of NHS esters is compared by their hydrolysis half-life (T1/2). To mitigate the competitive hydrolysis reaction, organic solvents such as amine-free, anhydrous DMF and DMSO may be used in combination with an aqueous buffer solution.

Table: Comparison of PEG NHS ester reactivity and stability.
PEG NHS esters Structural characteristics Amine reactivity Stability
Type A: SCM Methylene (CH2) linkage between PEG and NHS ester Highly reactive Hydrolysis half-life: less than five minutes. It often requires the use of a large excess of PEG reagents.
Type B: SG C4 aliphatic ester linkage between PEG and NHS ester Very reactive Hydrolysis half-life: around 20 minutes.
Type C: SS C3 aliphatic ester linkage between PEG and NHS ester Very reactive Hydrolysis half-life: around 10 minutes.
Type D: GAS C4 aliphatic amide linkage between PEG and NHS ester Very reactive Hydrolysis half-life: around 20 minutes.
Type E: SAS C3 aliphatic amide linkage between PEG and NHS ester Very reactive Hydrolysis half-life: around 10 minutes.

SCM: Succinimidyl Carboxyl Methyl ester; SG: Succinimidyl Glutarate ester; SS: Succinimidyl Succinate ester; GAS: GlutarAmide Succinimidyl ester; SAS: SuccinAmide Succinimidyl ester. Note: hydrolysis half-life depends on pH, temperature and other factors of the testing conditions.

Molecular weight: MW of PEG was measured by MALDI-MS or GPC. PDI (polydispersity index) of our linear PEG is 1.02-1.05 with very narrow MW distribution. The number of repeating ethylene oxide units (CH2CH2O) or the degree of polymerization is calculated dividing the PEG MW by 44 (44 is the molecular mass of one repeating unit).

Solubility: Soluble in water and aqueous buffer, chloroform, methylene chloride, DMF, DMSO, and less soluble in alcohol, toluene. Not soluble in ether.

Density: PEG density is approximately 1.125 g/mL

Physical form: PEG products generally appear as white or off-white powder, and for very low MW linear PEG such as MW 1k or less, it may appear as wax-like, semi-solid material due to the low MW and the type of functional groups.

Storage condition: PEG product shall be stored in the original form as received in a freezer at -20C or lower for long term storage. Stock solution of PEG reagents that do not contain oxygen or moisture sensitive functional groups may be temporarily stored in a refrigerator or ambient temperature for multiple days. Stock solution should avoid repeated freeze-and-thaw cycles. See Documents section for detailed storage and handling conditions.

References

1.  Molecular and Biocompatibility Characterization of Red Blood Cell Membrane Targeted and Cell-Penetrating-Peptide-Modified Polymeric Nanoparticles, Mol. Pharmaceutics, 2017, 14 (7), pp 2224–223, Text.

2. Targeting thyroid cancer with acid-triggered release of doxorubicin from silicon dioxide nanoparticles, Int J Nanomedicine.  2017; 12: 5993–6003, Text.

3.  RNA Fibers as Optimized Nanoscaffolds for siRNA Coordination and Reduced Immunological Recognition. Advanced Functional Materials. 2018:1805959.  Text.

4.  Effect of redox-responsive DTSSP crosslinking on poly(L-lysine)-grafted-poly(ethylene glycol) nanoparticles for delivery of proteins, Biotechnol  Bioeng.  2020, Text.

5.  Reprogramming the rapid clearance of thrombolytics by nanoparticle encapsulation and anchoring to circulating red blood cells, J. Controlled Release, 2020, Text.

Click here  to view an expanded list of hundreds of publications citing Creative PEGWorks products.

Documents

 Technical Information_Linear PEG Products
 SDS of mPEG-SAS

Get In Touch

If you have any questions, please submit an online inquiry.

"*" indicates required fields

Your Name*
Do you wish to receive emails for new product introduction and sale promotions?
By submitting this form, you are consenting to our privacy policy.
This field is for validation purposes and should be left unchanged.